AMRX (Amneal Pharmaceuticals, Inc.) operates in the Health technology sector. It's currently trading at $17.09. Our composite momentum score rates it 46/110 based on price +0.2% (1d) — modest gain, rsi 79.5 — overbought, roc9 +20.4% — sharp acceleration, macd 0.94 — strong bullish crossover, beta 1.22 — above-market volatility, and analyst: buy. Up 5.0% across 2 tracked price points, from Jul 7, 2026 to Jul 7, 2026.